nach oben

Erschienen in:

Open Access 01.12.2020 | Research

In-depth immune cellular profiling reveals sex-specific associations with frailty

verfasst von: Leonard Daniël Samson, A. Mieke H. Boots, José A. Ferreira, H. Susan J. Picavet, Lia G. H. de Rond, Mary-lène de Zeeuw-Brouwer, W. M. Monique Verschuren, Anne-Marie Buisman, Peter Engelfriet

Erschienen in: Immunity & Ageing | Ausgabe 1/2020

Abstract

Background

With advancing age, the composition of leukocyte subpopulations in peripheral blood is known to change, but how this change differs between men and women and how it relates to frailty is poorly understood. Our aim in this exploratory study was to investigate whether frailty is associated with changes in immune cell subpopulations and whether this differs between men and women. Therefore, we performed in-depth immune cellular profiling by enumerating a total of 37 subpopulations of T cells, B cells, NK cells, monocytes, and neutrophils in peripheral blood of 289 elderly people between 60-87 years of age. Associations between frailty and each immune cell subpopulation were tested separately in men and women and were adjusted for age and CMV serostatus. In addition, a random forest algorithm was used to predict a participant’s frailty score based on enumeration of immune cell subpopulations.

Results

In the association study, frailty was found to be associated with increased numbers of neutrophils in both men and in women. Frailer women, but not men, showed higher numbers of total and CD16^- monocytes, and lower numbers of both CD56⁺ T cells and late differentiated CD4⁺ TemRA cells. The random forest algorithm confirmed all the findings of the association studies in men and women. In men, the predictive accuracy of the algorithm was too low (5.5%) to warrant additional conclusions on top of the ones derived from the association study. In women however, the predictive accuracy was higher (23.1%), additionally revealing that total T cell numbers and total lymphocyte numbers also contribute in predicting frailty.

Conclusions

In-depth immune cellular profiling revealed consistent associations of frailty with elevated numbers of myeloid cell subpopulations in both men and women. Furthermore, additional associations were found between frailty and lower numbers of some T cell subpopulations, in women only. Thus, our study indicates sex-specific associations of immune subpopulations with frailty. We hope that our study will prompt further investigation into the sex-specific immune mechanisms associated with the development of frailty.

Additional file 1 upplementary Figures S1-S5 and Tables S1-S8.

Supplementary information

Supplementary information accompanies this paper at https://doi.org/10.1186/s12979-020-00191-z.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

CMV

Cytomegalovirus

DCS

Doetinchem cohort study

FDR

False discovery rate

Tem

Effector memory T cells

TemRA

Effector memory T cells re-expressing CD45RA

Background

While the biological process of aging is inevitable, some people remain healthy until an advanced age while others suffer from age-related diseases early in life. The reasons for these vastly different aging patterns are still poorly understood. To protect the body from damage normally associated with aging, a balanced immune system is needed [1], with different subpopulations of immune cells working in close harmony. One telling sign of a disturbed immune balance is a state of chronic low-grade inflammation, which may be revealed by measuring biomarkers such as C-reactive protein [1‐3]. It remains a challenge, however, to identify other biomarkers of the immune system that signal or explain differences in aging patterns.

Both innate and adaptive immune cell lineages are essential for a proper functioning of the immune system. It is well-established that the composition of the immune cell repertoire—that is the relative and absolute abundances of the various subpopulations of immune cells—changes with age [4]. However, it is largely unknown how changes in the immune cellular composition differ between individuals who age in good health from those who become frail at a relatively early age. Several studies have been performed on this subject, but some of these were done in the extreme elderly of 85 years old or above [5], while others focused on a limited set of lymphocyte phenotypes [6‐8]. Importantly, few studies have been performed enumerating a comprehensive set of immune phenotypes in freshly drawn whole blood samples.

Recently, we investigated associations between frailty and absolute numbers of the major immune cell populations in fresh whole blood. In that study, we detected associations between frailty and numbers of granulocytes and monocytes [3]. However, the complex functioning of the immune system involves a range of specialized functions that are mediated by various myeloid cells and lymphocytes. It is therefore to be expected that shifts in the major immune cell populations are accompanied by less visible, yet potentially important, changes in their subpopulations that are functionally distinct. This hypothesis prompted us to extend our previous study with an in-depth analysis of various immune cell subpopulations in relation to frailty.

Since men and women tend to age differently [9], we deemed it important to consider differences between the sexes. Furthermore, cytomegalovirus (CMV) serostatus should be taken into account, because chronic CMV infection is well known to impact numbers of immune cell subpopulations [10, 11].

Thus, our main goal in this exploratory study was to investigate how general health, expressed in terms of a frailty index, is associated with various immune cell subpopulations in peripheral blood of older adults. Our secondary goal was to explore how these cell populations differ between the sexes or according to CMV serostatus. In order to do so, we employed extensive immune profiling, enumerating 37 immune cell subpopulations and quantifying the expression of several surface markers on immune cells in fresh whole blood samples from 289 older people aged between 60-87 years that were selected from among the participants in an ongoing cohort study in the Netherlands [12, 13].

Methods

DCS subcohort selection

A subcohort was selected from the Doetinchem cohort study (DCS) [12, 13]. Details on this subcohort and its selection have been described previously [3]. Briefly, the study involved 289 active DCS participants, aged 60-87 years, who were selected as an age- and sex- stratified sample, with selection of equal numbers of the healthiest, intermediate, and frailest participants. By healthiest/frailest we mean those belonging to the 15% individuals with the lowest/highest frailty index score (see below for the definition of frailty index) compared to their age- and sex-matched peers. By intermediate we mean the remaining 70% of the DCS participants.

Frailty index

A frailty index was constructed based on previous studies [5, 14‐16] and was adapted to the data available in the DCS; it was recently validated within the DCS by [3]. This frailty index incorporates 36 possible “health deficits” such as presence of (a particular) chronic disease or reduced physical functioning. The values of the frailty index are restricted to lie between zero and one, zero representing the ‘best’ (0 out of 36 deficits present) and one representing the ‘worst’ (all 36 deficits present) health status. Since it has 36 categories, this frailty index is by approximation a continuous variable. Using the index, a frailty ‘score’ was calculated for each individual, based on data collected during the DCS assessment round 6 (2012-2017). Twelve out of 289 individuals who participated in our DCS subcohort, had not participated in DCS assessment round 6 and thus, their frailty index scores were missing.

Whole blood lymphocyte phenotyping

Fresh whole blood samples from the DCS subcohort participants were collected between August 2016 and March 2017, and were processed and analyzed within 6 hours on a 4-laser LSRII Fortessa X20 flow cytometer (BD Biosciences) for absolute numbers of leukocyte subpopulations (cell counts μL^-1). Two labeled antibody panels per participant were used with a lyse-no-wash protocol, one in a TruCOUNT\(^{\circledR }\) tube (BD Biosciences) and one in a common (Falcon) tube. In both panels we used the fluorochrome-conjugated antibodies CD3(UCHT1)-BV711 (BD) and CD27(M-T271)-BV421 (Biolegend). In the TruCOUNT\(^{\circledR }\) tube, we additionally used CD56(B159)-APC, CD8(SK1)-FITC, CD16(B73.1)-PE, CD4(SK3)-PerCPCy5.5, IgD(ia6-2)-BB515, CD38(HB7)-APC-H7, HLA-DR(G46.6)-PECF594 (all BD Biosciences), CD19(J3-119)-PECy7 (Beckman Coulter), and CD45(GA90)-OC515 (Cytognos). In the second tube we additionally used the following fluorochrome-conjugated antibodies: CD127(hIL-7R-M21)-PE, CD25(2A3)-BB515, CCR7(150503)-PECF594, CD28(CD28.2)-PerCPCy5.5, CD8(SK1)-APC-H7 (all BD Biosciences), CD4(RPA-T4)-BV510, CD45RA(HI100)-BV650 (all Biolegend), and CXCR5(51505)-APC (R&D Systems). Absolute cell numbers in the Falcon tubes were calculated by using the CD3 T cell ratio between both tubes and the bead count in the TruCOUNT\(^{\circledR }\) tube.

For phenotype definitions and gating strategies, see Table S1 and Figures S1–S3. Neutrophils were gated as CD45 and SSC^BRIGHT and CD45^DIM and were additionally analyzed not only regarding cell numbers but also with respect to CD16 expression. CD16 is usually expressed on the surface of neutrophils [17] and is seen as a neutrophil maturation marker [18]. Lower expression of CD16 by neutrophils was seen in several diseases and in states of neutropenia [19]. Monocytes were gated as SSC^DIMCD45^DIM and, to ensure that B cells or T cells did not contaminate the gate, as CD3^-CD19^-. Monocytes were further sub-classified into CD16^- and CD16⁺ monocytes and were additionally analyzed based on the expression of HLA-DR and CD38, since HLA-DR expression on monocytes is thought to be lower [20] and CD38 expression higher [21] in inflammatory conditions. NK cells were gated and subdivided based on their CD16 and CD56 expression [22]. For memory T cells and regulatory T cells, gating was done as described previously [23‐25] and was performed similarly in both CD4⁺ and CD8⁺ T cells. In short, CCR7⁺ CD4⁺/CD8⁺ T cells were classified as either naïve (CD45RA⁺CCR7⁺) or central memory (CCR7⁺CD45RA^-) T cells. CCR7^- CD4⁺/CD8⁺ T cells were divided into effector memory T cells (Tem, CCR7^-CD45RA^-) and effector memory T cells re-expressing CD45RA (TemRA, CCR7^-CD45RA⁺) T cells. Finally, these T cells were further subclassified into early (CD27⁺CD28⁺) and late stage (CD27^-CD28^-) Tem or TemRA cells. The B cell subpopulations were defined by means of CD19, CD27, and CD38 expression [24], with naïve B cells defined as CD19⁺CD38^DIMCD27^- and memory B cells as CD19⁺CD38^DIMCD27⁺ (Figure S3 and Table S1). As an additional analysis, we also calculated proportions of the immune cell subpopulations. Proportions were expressed as the percentage of their major cell lineage (T cells, B cells, NK cells, or monocytes) or, for all CD4⁺ and CD8⁺ subpopulations, as the percentage of CD4⁺ and CD8⁺ T cells, respectively.

Some subpopulations were not clearly distinguishable from debris and the corresponding data were excluded from analysis. This occurred for the general lymphocyte subpopulation in four participants, for the monocyte subpopulations in three participants, and for both the lymphocyte and monocyte subpopulations in three participants. Unwanted fluorochrome excitation spillover was automatically corrected for by using BDComp beads (BD Biosciences). Gating of cellular subpopulations was performed in FlowJo V10 (FlowJo company).

Anti-cytomegalovirus antibodies

IgG antibodies against CMV were quantified using a multiplex immunoassay (MIA) that was developed in-house and was based on a commercially available Cytomegalovirus IgG ELISA kit (EUROIMMUN, Germany) [26]. A cutoff for CMV-seropositivity was calculated by first pooling IgG CMV antibody concentrations of people from multiple cohorts [3, 27‐29], with all concentrations measured using the same in-house developed assay (n=1415, age range: 4-89 years). With these pooled concentrations, we used mixture modeling [30] to define two distributions, representing respectively CMV-seronegative and CMV-seropositive individuals. The CMV-seropositivity cutoff was defined as the intersection between the two distributions, as described previously for varicella zoster virus [31].

Statistical methods

Overall plan of analysis

The aim of the statistical analyses was to investigate the relation between the various leukocyte subpopulations and the characteristics of interest, namely sex, CMV status and frailty, the latter being our main focus. In order to analyze these relationships, we used bivariate analyses in association studies, which are described in detail below. We also performed multivariate analyses to study the collective effect of the leukocyte subpopulations on frailty. Both in the bivariate and in the multivariate analysis, we used non-parametric methods because these depend on fewer assumptions regarding the underlying data such as normality of distribution, and are thus less prone to lead to invalid conclusions. For the multivariate analysis, with frailty as dependent variable, we used the random forest algorithm. All analyses were performed using R version 3.6.0 [32] and several tidyverse packages [33]. Figures were generated with the R packages ggplot2 (part of tidyverse) and cowplot [34].

Association studies

In the bivariate association studies, we used the permutation version of the Wilcoxon-Mann-Whitney test to analyze the associations between each leukocyte subpopulation and sex [35]. We used the same test to analyze the associations between each leukocyte subpopulation and CMV serostatus, separately for men and women. The permutation version of the Spearman test was used to analyze the associations between each of the leukocyte subpopulations with frailty, also separately for men and women [35]. These tests (both implemented in the coin package of R) are based on ranking the variables in order of magnitude. P-values were calculated using simulations, for which we set the number of simulations at 10⁸. In order to take into account potential confounding due to age or CMV status, we stratified the analyses using a block design. The “blocks” were defined based on a division according to age into four age groups for all analyses, and also according to CMV status into positive and negative status for the associations between the sexes and for the ones with frailty. To quantify the strength of the correlations with frailty, we calculated the weighted average of Spearman’s rho per block. In order to account for multiple testing, we implemented the Benjamini Hochberg method [36] separately for each association study, applying a False Discovery Rate (FDR) of 15%.

Random forest analysis

We complemented the association study regarding frailty with a multivariate analysis. The cell subpopulations were entered into a prediction study using the random forest algorithm [37]. That is, a participant’s frailty index was predicted with these variables together with age, CMV serostatus and date of flow cytometry measurement. The random forest algorithm ranks the independent variables according to their ‘importance’, or influence, in predicting the dependent variable (frailty). The importance of a variable is expressed in terms of the percentage increase in mean-square error (MSE) when the effect of that variable is removed. The overall performance of the prediction analysis was assessed in terms of the percentage explained variance. The frailty index score was transformed by taking the square root, in order to obtain a more symmetric distribution. In order to obtain a qualitative idea of the relationships between the most important predictor variables and the frailty index, partial dependence plots were created with the pdp R package [38], showing the magnitude and direction of the effect of the respective variables on frailty.

Results

Study population

The study population consisted of 145 men and 144 women. Average time between blood sample collection and frailty index measurement was 1.6 years (95%CI: 1.4-1.8 years, min: 2 days, max: 4.25 years). Since five men and seven women did not participate in the latest DCS assessment round and therefore had a missing frailty index score for that round, these participants were removed from the analyses with frailty.

Associations between leukocyte subpopulations and sex

An overview of immune cell phenotypes considered in this study is given in Fig. 1, all of them measured in peripheral blood. Most of the analyzed subpopulations belong to the T cell lineage, as in the literature these have been reported to be affected by aging and CMV [10, 11, 39]. Neutrophils accounted for the highest median numbers in peripheral blood of both men and women, followed by T cells (Fig. 2). Women had lower numbers of CD16^- (classical) monocytes but higher numbers of B cells and T cells than men. Cell numbers were higher in women for almost all measured B cell subpopulations, namely for transitional B cells, naïve B cells, and memory B cells. The higher numbers of T cells in women were mainly due to higher CD4⁺ T cell numbers. Further subsetting revealed higher concentrations of almost all CD4 T cell subpopulations (naïve CD4 T cells, central memory CD4 T cells, CD4 Tem and TemRA cells, (naïve) regulatory T cells, and Follicular helper T cells) in peripheral blood of women. This pattern was also seen in early differentiated CD4 subpopulations but, in contrast, not in late differentiated CD4 Tem cells which showed lower numbers in women (Fig. 3). The association of lower late differentiated CD4 Tem numbers in women would have been missed without stratification for CMV serostatus since the association was mainly seen in CMV seropositive women (data not shown). Furthermore, we also observed lower numbers of CD56⁺ T cells in women (Fig. 2). While total numbers of CD8⁺ T cells were not found to be different between the sexes, CD8 naïve T cell numbers were observed to be higher in women (Fig. 2). More detailed phenotyping of CD8 T cell subpopulations revealed higher numbers of early differentiated CD8 Tem and TemRA cells in women than in men, but lower numbers of late differentiated CD8 Tem and TemRA cells (Fig. 3).

Associations between leukocyte subpopulations and CMV serostatus

CMV seropositivity was associated with higher numbers of T cells and CD56⁺ T cells in men and in women (Table S2). Numbers of CD8⁺ T cells were observed to be higher in CMV seropositive (CMV⁺) men and CMV⁺ women, which was mainly due to higher numbers of late stage CD8⁺ Tem and TemRA cells. Numbers of CD4⁺ T cells were observed to be higher in CMV⁺ men but not in CMV⁺ women. However, late stage CD4⁺ Tem and TemRA cells were higher in CMV⁺ men and CMV⁺ women. Also, the CD4/CD8 ratio was lower in CMV seropositive individuals of both sexes, indicating that the higher T cell numbers in CMV⁺ participants was due to the higher numbers of CD8⁺ T cells rather than to the CD4⁺ T cells. In men, CMV seropositivity was also associated with higher numbers of follicular helper T cells and with lower numbers of monocytes due to lower numbers of CD16^- (classical) monocytes. These classical monocytes also showed higher CD38 expression.

Relationship of frailty with leukocyte subpopulations

In the association study, an association between frailty and higher neutrophil numbers was found in both men and women (tables S3 and S4; ρ=0.25 and ρ=0.4, respectively), while other associations were observed only in women. Frailer women, but not men, showed higher monocyte numbers (ρ=0.23), in particular CD16^- classical monocyte numbers (ρ=0.24). In addition, frailer women also showed lower CD56⁺ T cell numbers (ρ=-0.20) and lower CD4⁺ TemRA cell numbers (ρ=-0.13). Interestingly, frailty was not found to be associated with any other T cell subpopulation and thus, not with most memory T cell subpopulations. The results remained the same in a sensitivity analysis in which we restricted monocytes populations to be HLADR⁺. This showed that the associations found were not due to possible contamination of monocyte populations with NK cells and neutrophils (Table S5 and S6).

The prediction analysis, using the random forest algorithm, turned out to have low predictive power for frailty in men (5.5% PEV, i.e. proportion of explained variance). Therefore, it did not allow to confidently identify additional relations other than the ones found in the association study. The cell population highest in ranking of variable importance were neutrophils, closely followed by CD16⁺ monocytes (Fig. 4). In women however, the predictive accuracy was higher (23.1% PEV), implying that more of the relationships between cell populations and frailty could be confidently concluded to be ‘important’. Highest in ranking of variable importance in women were neutrophils followed by CD16- monocytes, total monocytes, CD56⁺ T cells, total T cells, lymphocytes and CD4 TemRA cells, thereby largely confirming the findings of the association study. In addition to these, relationships of frailty with total T cells and lymphocyte numbers were identified as being of similar importance as CD56⁺ T cells and CD4⁺ TemRA cells. Age also ranked high in both men and women. Noteworthy is that CMV serostatus was not important in the prediction models, with an increase in MSE of less than 7% in both sexes (data not shown).

An impression of the role of the more important variables in predicting frailty, both with regard to the strength and the direction of the effect, is provided by the partial dependence plots shown in Fig. 5 and Figure S4. These show the marginal ‘effect’ of a cell type on frailty, meaning the ‘effect’ of a cell type on frailty when the other variables in the random forest predictor are held constant at average values. The clearer and stronger relationships with frailty were seen in numbers of several myeloid cell populations (Fig. 5). The frailty index was higher with increasing neutrophil numbers in both men and women which was in accordance with the results of the association study. Numbers of classical monocytes (Fig. 5) and total monocytes (Figure S4) increased with frailty but only in women. Numbers of non-classical monocytes increased with frailty in men. However, this increase was only seen in the few participants with the highest (top 10%) CD16⁺ monocyte numbers (see Fig. 5 and its legend for explanation). In frailer women, a decrease was seen in numbers of CD56⁺ T cells, CD4⁺ TemRA cells, total T cells, and lymphocytes, although the marginal ‘effect’ was small. An explanation why the total numbers of T cells and lymphocytes in women were found to be of relevance in the random forest algorithm but not in the association study, may be found in interactions with other variables, which can be missed in an association study. To illustrate this, we investigated the joint relationship of total numbers of T cells and CD56⁺ T cells with frailty, which showed that the frailty score tended to be lowest when both total T cell numbers and CD56⁺ T cell numbers are high (Figure S5).

Associations between frailty and proportions of leukocyte subpopulations

In addition, we investigated whether frailty was associated with relative values (percentages) of immune cell subpopulations within the major parent populations (that is, within T cells, B cells, monocytes, and NK cells). In this analysis, no associations with frailty were detected (Tables S5 and S6).

Discussion

This study shows that frailty in a 60-87-year-old population was associated with higher absolute numbers of neutrophils in men and women, and also with several sex-specific changes in the immune cellular profile. To the best of our knowledge, this is the first study in which frailty was separately investigated in men and women for its relations with a wide variety of immune cell subpopulations. Frailer women demonstrated higher numbers of total- and CD16^- monocytes, lower numbers of CD56⁺ T cells, and lower numbers of late differentiated CD4⁺ TemRA T cells. These findings, obtained from association studies, were confirmed in a random forest prediction analysis. In men, the predictive value of the random forest analysis was too low to warrant substantial additional conclusions on top of the ones from the association study. The highest ranking subpopulation based on variable importance were neutrophils, in line with the association study. Based on variable importance, also CD16⁺ monocytes may play a role in prediction of frailty, but since this subpopulation was not found in the association study and the predictive accuracy was low, the relationship between CD16⁺ monocytes and frailty in men is unclear. In women, however, the predictive value of the random forest analysis was higher than in men and additional potentially relevant relationships were found with, respectively, total numbers of T cells and lymphocytes.

The associations found between higher neutrophil numbers and frailty are in line with previous reports [3, 5, 40]. Among the entire immune cellular profile we investigated, neutrophil numbers were most strongly associated with frailty and the association was found in both men and women. In a previous study it was shown that elevated neutrophil levels in humans are related to negative health outcomes [41], which corresponds to our results, since frail people are more prone to adverse outcomes like early mortality. The association of total monocyte numbers with frailty in women was also in line with other studies [3, 40]. We have now shown that the relationship of higher monocyte numbers with frailty in women was due to higher numbers of CD16^- classical monocytes. The classical CD16^- monocytes, having clear phagocytic capacity, further differentiate into macrophages [42], and are therefore involved in the defense against pathogens and in inflammation. Classical monocytes have a short lifespan of approximately one day in the circulation [43]. Thus, an increase in this population is likely due to an increased production by myeloid progenitor cells rather than due to reduced clearance.

Noteworthy is that the clearest associations with frailty found in our study were with myeloid cells. In a murine study, it was argued that both higher myeloid cell abundancies and lower vaccine responses in older mice could be the result of intrinsic differences in hematopoietic stem cells with age [44]. Other studies suggested that the myeloid bias of hematopoietic stem cell differentiation seen in old age is due to a chronic low-grade inflammation [45]. This stronger tendency of hematopoietic stem cells to differentiate in the myeloid direction in an environment of low-grade inflammation is possibly driven by plasma cells in the bone marrow that can produce pro-inflammatory cytokines which also influence myelopoiesis [46]. Such a chronic low-grade inflammation is often seen in frail people [47], with a role for the IL-6 pathway, since consistent associations have been reported between frailty and higher CRP levels [47]. Parallel to the more pronounced myeloid skewing with frailty in women, the association of chronic low-grade inflammation with frailty is also more pronounced in women than in men [3]. However, many other factors may impact cellular numbers in peripheral blood, like variations in extravascular homing, or differential apoptosis [48], which could explain the great variability between participants seen in our study population.

The present study also shows that several immune cell subpopulations differ in abundancy between the sexes, with higher numbers of most T cell subpopulations, especially CD4 T helper cells, and higher numbers of B cells, in women. These findings are in line with previous studies [25]. We also found sex-specific associations between frailty and lower numbers of several CD4 T cell subpopulations in women but not men, which has not been reported earlier. These results, together with the stronger associations between frailty and myeloid cell numbers in women, could suggest that the skewing of hematopoietic stem cells with frailty towards production of myeloid cells is more pronounced in women than in men. Immunological homeostasis in women may involve a different balance between CD4 and CD8 T cells than in men, with estrogen levels known to be involved in lymphocyte development and in particular CD4 T cell proliferation [49, 50]. In addition, immune function differs between the sexes, with women showing stronger responses to antigens and a stronger tendency to develop autoimmune diseases [49, 51]. Testosterone levels are also thought to impact this process, with testosterone possibly having an anti-inflammatory role [52]. The sex-specific findings in our study could also be of interest in relation to the so-called sex-frailty paradox, namely that women generally tend to be frailer, yet live longer than men [51]. In our study, frailer women had lower numbers of CD56⁺ T cells, which are known for their cytotoxic capacity [53]. While the relationship of frailty with CD56⁺ T cells has not been described previously, in one study NK cell markers (CD16 and CD56) were shown to be more highly expressed by T cells from people with better cognitive and physical functioning [54], which is in line with our findings. CD4⁺ TemRA T cell numbers were also found to be lower in frailer women. Since this was the weakest association in women, it would require confirmation in future studies. In fact, we expected to observe a negative correlation, i.e. meaning an increase of T cell memory numbers with frailty, instead of a lower number. It is known that the balance between naïve and memory T cells in peripheral blood changes with advancing age, mainly due to a decline in numbers of naïve (CD8⁺) T cells [11, 55, 56], which was also observed in our study (data not shown). Only few studies reported relationships between T cell populations and frailty and, to our knowledge, no associations were reported with late differentiated CD4⁺ TemRA T cells. In one study, frailty was related to lower naïve CD4⁺ T cells [8], in another one with lower CD4⁺ central memory (CD27⁺CD45RA^-) T cells [6], while in a third study no association was found between T cell subpopulations and frailty [5]. Reasons for these heterogeneous results could arise from differences in gating strategies, not separating results for men and women, or not adjusting for CMV serostatus. Moreover, all previous studies involving memory T cell subpopulations were performed with relative values (percentages) rather than absolute cell numbers. Nevertheless, we found a relationship between frailty and lower numbers of total T cells in women. This relationship showed possible interactions with age and with numbers of CD56⁺ T cells, which could explain why it was detected in the random forest analysis but not in the association study.

In our study we confirmed previously reported associations of CMV seropositivity with the late-stage memory T cell population [11, 25]. We also observed that CMV seropositive men had lower classical monocyte numbers. In addition, their classical monocytes seemed to have higher CD38 expression. It is thought that CD38 can be upregulated in monocytes and macrophages in inflammatory conditions [21]. Further research is needed to confirm this association and to answer the question why it was only found in men. Furthermore, we observed that CMV serostatus was not important in our frailty prediction model. Conflicting evidence has been reported on whether there is a positive relationship between CMV serostatus and frailty, with some studies showing an association [57, 58] while others do not [5, 59]. These conflicting results might be explained by differences instruments used to evaluate frailty (frailty phenotype or frailty index), or differences in study population, with some studies being restricted to only one of the sexes [57] or to extreme elderly [5, 59].

A major strength of this study is the use of fresh whole blood samples to measure an extensive set of immune cell subpopulations. This made it possible to enumerate cell populations like neutrophils that cannot be quantified when using cryopreserved PBMCs. In addition, we were able to relate absolute numbers of 37 immune cell subpopulations to frailty. This is important as these are needed to correctly interpret relative values (e.g. percentages). For example, a change in relative values can be the result of a change in either the numerator or the denominator. This issue can be solved only with information on absolute numbers. Our study showed that, when we performed an analysis with subpopulations of B cells, T cells, NK cells, and monocytes expressed as percentages, this analysis did not give additional insight in how frailty relates to the immune cellular profile. Another strength of our study is the use of a robust statistical analysis framework with two different analytical approaches that complement each other to find associations with frailty while correcting for multiple testing. The analysis framework that we used performs well when there is a high number of explanatory variables and strong multicollinearity, as was the case in our study. In particular, the random forest algorithm is known for its accuracy in complex analyses when many explanatory variables are involved [60‐62]. This algorithm made it possible to investigate how frailty is related to all cellular subpopulations together, i.e. the ‘cellular immune profile’. Of note is that we also used a quantitative measure of frailty that was defined in a consistent manner and implemented in a richly documented population, allowing the inclusion of 36 health characteristics. This made it possible to study the relation between frailty and immune cell subpopulations in a quantified manner. Lastly, our cohort consisted of a sample from the general community-dwelling population, thus allowing a window on aging of the immune system in a non-clinical setting. On the other hand, due to the nature of using fresh whole blood samples and our aim to quantify a large number of different immune cell subpopulations, we were restricted in the coverage of our antibody panel and therefore not all the subpopulations could be further classified with additional phenotypic markers. For example, to define regulatory T cells we used CD45RA and CD25 as was done previously [23‐25], but not FoxP3 or CD127. In addition, it appeared, as already expected, that the variability in numbers of immune cell subpopulations is very large in older adults. This may have contributed to the low predictive accuracy observed in the prediction analysis. Furthermore, there is no consensus yet on which instrument is the best to investigate frailty, and different instruments might yield different results. Since we were interested in a measure that approximates general health, we used a Rockwood frailty index [16] based on 36 deficits rather than a frailty instrument with a less broad definition like the Fried frailty phenotype [63].

Conclusions

The in-depth immune cellular profiling that we performed in this study showed that, among all investigated subpopulations, neutrophils were most strongly associated with frailty in men and women. In addition, sex-specific associations with frailty were revealed, with frailer women but not men showing higher numbers of classical (CD16^-) monocytes and lower numbers of CD56⁺ T cells and late differentiated CD4⁺memory T cells than their healthier peers. An expected positive association between frailty and memory T cells was not observed. These results add to the evidence that frailty manifests differently in men and women. We hope that this will prompt further investigation into the different immune mechanisms associated with the development of frailty.

Supplementary information

Supplementary information accompanies this paper at https://doi.org/10.1186/s12979-020-00191-z.

Acknowledgements

We would like to thank the DCS respondents for their participation in the study and the epidemiologists and fieldworkers of the Municipal Health Service in Doetinchem for their contribution to the data collection. In addition, we would like to thank Petra Vissink for her help with the blood sample collection, and Sara van den Berg, Marjan Bogaard, and Irina Tcherniaeva for their help with the cytomegalovirus assay.

The study was approved by the Medical Ethics Committee of the University Medical Center in Utrecht, The Netherlands. The participants gave written informed consent for every DCS round and for this subcohort study separately.

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

Additional file 1 upplementary Figures S1-S5 and Tables S1-S8.

Campisi J, Kapahi P, Lithgow GJ, Melov S, Newman JC, Verdin E. From discoveries in ageing research to therapeutics for healthy ageing. Nature. 2019; 571(7764):183–92. https://doi.org/10.1038/s41586-019-1365-2.PubMedPubMedCentral

Franceschi C, Campisi J. Chronic inflammation (inflammaging) and its potential contribution to age-associated diseases. J Gerontol A Biol Sci Med Sci. 2014; 69(Suppl 1):4–9. https://doi.org/10.1093/gerona/glu057.

Samson LD, Boots AMH, Verschuren WMM, Picavet HSJ, Engelfriet P, Buisman A-M. Frailty is associated with elevated CRP trajectories and higher numbers of neutrophils and monocytes. Exp Gerontol. 2019; 125:110674. https://doi.org/10.1016/j.exger.2019.110674.PubMed

Carr EJ, Dooley J, Garcia-Perez JE, Lagou V, Lee JC, Wouters C, Meyts I, Goris A, Boeckxstaens G, Linterman MA, Liston A. The cellular composition of the human immune system is shaped by age and cohabitation. Nat Immunol. 2016; 17(4):461–8. https://doi.org/10.1038/ni.3371.PubMedPubMedCentral

Collerton J, Martin-Ruiz C, Davies K, Hilkens CM, Isaacs J, Kolenda C, Parker C, Dunn M, Catt M, Jagger C, von Zglinicki T, Kirkwood TB. Frailty and the role of inflammation, immunosenescence and cellular ageing in the very old: Cross-sectional findings from the Newcastle 85+ Study. Mech Ageing Dev. 2012; 133(6):456–66. https://doi.org/10.1016/j.mad.2012.05.005.PubMed

Lu Y, Tan CTY, Nyunt MSZ, Mok EWH, Camous X, Kared H, Fulop T, Feng L, Ng TP, Larbi A. Inflammatory and immune markers associated with physical frailty syndrome: Findings from Singapore longitudinal aging studies. Oncotarget. 2016; 7(20):28783. https://doi.org/10.18632/oncotarget.8939.PubMedPubMedCentral

Marcos-Pérez D, Sánchez-Flores M, Maseda A, Lorenzo-López L, Millán-Calenti JC, Gostner JM, Fuchs D, Pásaro E, Laffon B, Valdiglesias V. Frailty in older adults is associated with plasma concentrations of inflammatory mediators but not with lymphocyte subpopulations. Front Immunol. 2018; 9:1056. https://doi.org/10.3389/fimmu.2018.01056.PubMedPubMedCentral

Johnstone J, Parsons R, Botelho F, Millar J, McNeil S, Fulop T, McElhaney JE, Andrew MK, Walter SD, Devereaux PJ, Malek M, Brinkman RR, Bramson J, Loeb M. T-cell phenotypes predictive of frailty and mortality in elderly nursing home residents. J Am Geriatr Soc. 2017; 65(1):153–9. https://doi.org/10.1111/jgs.14507.PubMed

Gordon EH, Peel NM, Samanta M, Theou O, Howlett SE, Hubbard RE. Sex differences in frailty: A systematic review and meta-analysis. Exp Gerontol. 2017; 89:30–40. https://doi.org/10.1016/j.exger.2016.12.021.PubMed

10.

Apoil PA, Puissant-Lubrano B, Congy-Jolivet N, Peres M, Tkaczuk J, Roubinet F, Blancher A. Influence of age, sex and HCMV-serostatus on blood lymphocyte subpopulations in healthy adults. Cell Immunol. 2017; 314:42–53. https://doi.org/10.1016/j.cellimm.2017.02.001.PubMed

11.

Wertheimer AM, Bennett MS, Park B, Uhrlaub JL, Martinez C, Pulko V, Currier NL, Nikolich-Zugich D, Kaye J, Nikolich-Zugich J. Aging and cytomegalovirus infection differentially and jointly affect distinct circulating T cell subsets in humans. J Immunol. 2014; 192(5):2143–55. https://doi.org/10.4049/jimmunol.1301721.PubMedPubMedCentral

12.

Picavet HSJ, Blokstra A, Spijkerman AMW, Verschuren WMM. Cohort Profile Update: The Doetinchem Cohort Study 1987-2017: Lifestyle, health and chronic diseases in a life course and ageing perspective. Int J Epidemiol. 2017; 46(6):1751. https://doi.org/10.1093/ije/dyx103.PubMedPubMedCentral

13.

Verschuren WM, Blokstra A, Picavet HS, Smit HA. Cohort profile: The Doetinchem Cohort Study. Int J Epidemiol. 2008; 37(6):1236–41. https://doi.org/10.1093/ije/dym292.PubMed

14.

Rockwood K, Song X, Mitnitski A. Changes in relative fitness and frailty across the adult lifespan: Evidence from the Canadian National Population Health Survey. Can Med Assoc J. 2011; 183(8):487–94. https://doi.org/10.1503/cmaj.101271.

15.

Schoufour JD, Erler NS, Jaspers L, Kiefte-de Jong JC, Voortman T, Ziere G, Lindemans J, Klaver CC, Tiemeier H, Stricker B, Ikram AM, Laven JS, Brusselle GG, Rivadeneira F, Franco OH. Design of a frailty index among community living middle-aged and older people: The Rotterdam study. Maturitas. 2017; 97:14–20. https://doi.org/10.1016/j.maturitas.2016.12.002.PubMed

16.

Searle SD, Mitnitski A, Gahbauer EA, Gill TM, Rockwood K. A standard procedure for creating a frailty index. BMC Geriatr. 2008; 8:24. https://doi.org/10.1186/1471-2318-8-24.PubMedPubMedCentral

17.

Lakschevitz FS, Hassanpour S, Rubin A, Fine N, Sun C, Glogauer M. Identification of neutrophil surface marker changes in health and inflammation using high-throughput screening flow cytometry. Exp Cell Res. 2016; 342(2):200–9. https://doi.org/10.1016/j.yexcr.2016.03.007.PubMed

18.

Fujimoto H, Sakata T, Hamaguchi Y, Shiga S, Tohyama K, Ichiyama S, Wang FS, Houwen B. Flow cytometric method for enumeration and classification of reactive immature granulocyte populations. Cytometry. 2000; 42(6):371–8. https://doi.org/10.1002/1097-0320(20001215)42:6<371::aid-cyto1004>3.0.co;2-g.PubMed

19.

Riera N, Canalejo K, Aixalá M, Rosso M, Gaddi E, Bracco MMDED, Galassi N. Detection of CD16low neutrophil subpopulations. Cytom Part B: Clin Cytom. 2003; 1:45–6. https://doi.org/10.1002/cyto.b.10004.

20.

Kim O, Monsel A, Bertrand M, Coriat P, Cavaillon J-M, Adib-Conquy M. Differential down-regulation of HLA-DR on monocyte subpopulations during systemic inflammation. Crit Care. 2010; 14(2):61. https://doi.org/10.1186/cc8959.

21.

Amici SA, Young NA, Narvaez-Miranda J, Jablonski KA, Arcos J, Rosas L, Papenfuss TL, Torrelles JB, Jarjour WN, Guerau-de-Arellano M. CD38 is robustly induced in human macrophages and monocytes in inflammatory conditions. Front Immunol. 2018; 9:1593. https://doi.org/10.3389/fimmu.2018.01593.PubMedPubMedCentral

22.

Michel T, Poli A, Cuapio A, Briquemont B, Iserentant G, Ollert M, Zimmer J. Human CD56bright NK cells: an update. J Immunol. 2016; 196(7):2923–31. https://doi.org/10.4049/jimmunol.1502570.PubMed

23.

Miyara M, Yoshioka Y, Kitoh A, Shima T, Wing K, Niwa A, Parizot C, Taflin C, Heike T, Valeyre D, Mathian A, Nakahata T, Yamaguchi T, Nomura T, Ono M, Amoura Z, Gorochov G, Sakaguchi S. Functional delineation and differentiation dynamics of human CD4+ T cells expressing the FoxP3 transcription factor. Immunity. 2009; 30(6):899–911. https://doi.org/10.1016/j.immuni.2009.03.019.PubMed

24.

van den Heuvel D, Jansen MAE, Nasserinejad K, Dik WA, van Lochem EG, Bakker-Jonges LE, Bouallouch-Charif H, Jaddoe VWV, Hooijkaas H, van Dongen JJM, Moll HA, van Zelm MC. Effects of nongenetic factors on immune cell dynamics in early childhood: the Generation R Study. J Allergy Clin Immunol. 2017; 139(6):1923–34. https://doi.org/10.1016/j.jaci.2016.10.023.PubMed

25.

van der Heiden M, van Zelm MC, Bartol SJ, de Rond LG, Berbers GA, Boots AM, Buisman AM. Differential effects of Cytomegalovirus carriage on the immune phenotype of middle-aged males and females. Sci Rep. 2016; 6:26892. https://doi.org/10.1038/srep26892.PubMedPubMedCentral

26.

Tcherniaeva I, den Hartog G, Berbers G, van der Klis F. The development of a bead-based multiplex immunoassay for the detection of IgG antibodies to CMV and EBV. J Immunol Methods. 2018; 462:1–8. https://doi.org/10.1016/j.jim.2018.07.003.PubMed

27.

Loef B, van Baarle D, van der Beek AJ, van Kerkhof LW, van de Langenberg D, Proper KI. Klokwerk+ study protocol: An observational study to the effects of night–shift work on body weight and infection susceptibility and the mechanisms underlying these health effects. BMC Public Health. 2016; 16(1):692. https://doi.org/10.1186/s12889-016-3317-1.PubMedPubMedCentral

28.

van Beek J, Veenhoven RH, Bruin JP, van Boxtel RAJ, de Lange MMA, Meijer A, Sanders EAM, Rots NY, Luytjes W. Influenza-like illness incidence is not reduced by influenza vaccination in a cohort of older adults, despite effectively reducing laboratory-confirmed influenza virus infections. J Infect Dis. 2017; 216(4):415–24. https://doi.org/10.1093/infdis/jix268.PubMedPubMedCentral

29.

Verberk JDM, Vos RA, Mollema L, van Vliet J, van Weert JWM, de Melker HE, van der Klis FRM. Third national biobank for population-based seroprevalence studies in the Netherlands, including the Caribbean Netherlands. BMC Infect Dis. 2019; 19(1):470. https://doi.org/10.1186/s12879-019-4019-y.PubMedPubMedCentral

30.

Benaglia T, Chauveau D, Hunter DR, Young D. mixtools: An R package for analyzing finite mixture models. J Stat Softw. 2009; 32(6). https://doi.org/10.18637/jss.v032.i06.

31.

van Lier A, Smits G, Mollema L, Waaijenborg S, Berbers G, van der Klis F, Boot H, Wallinga J, de Melker H. Varicella zoster virus infection occurs at a relatively young age in The Netherlands. Vaccine. 2013; 31(44):5127–33. https://doi.org/10.1016/j.vaccine.2013.08.029.PubMed

32.

R Core Team. R: A Language and Environment for Statistical Computing. Vienna: R Foundation for Statistical Computing; 2019. https://www.R-project.org/.

33.

Wickham H. tidyverse: Easily Install and Load the ‘Tidyverse’. 2017. R package version 1.2.1. https://CRAN.R-project.org/package=tidyverse.

34.

Wilke CO. cowplot: Streamlined Plot Theme and Plot Annotations for ‘ggplot2’. 2019. R package version 1.0.0. https://CRAN.R-project.org/package=cowplot.

35.

Hothorn T, Hornik K, van de Wiel MA, Zeileis A. Implementing a class of permutation tests: the coin package. J Stat Softw. 2008; 28(8):1–23. https://doi.org/10.18637/jss.v028.i08.

36.

Benjamini Y, Hochberg Y. Controlling the false discovery rate: A practical and powerful approach to multiple testing. J R Stat Soc Ser B Methodol. 1995; 57(1):289–300. https://doi.org/10.2307/2346101.

37.

Liaw A, Wiener M. Classification and regression by randomForest. R News. 2002; 2(3):18–22.

38.

Greenwell BM. Pdp: An R package for constructing partial dependence plots. R Journal. 2017; 9(1):421–36.

39.

Elyahu Y, Hekselman I, Eizenberg-Magar I, Berner O, Strominger I, Schiller M, Mittal K, Nemirovsky A, Eremenko E, Vital A, Simonovsky E, Chalifa-Caspi V, Friedman N, Yeger-Lotem E, Monsonego A. Aging promotes reorganization of the CD4 T cell landscape toward extreme regulatory and effector phenotypes. Sci Adv. 2019; 5(8):8330. https://doi.org/10.1126/sciadv.aaw8330.

40.

Leng SX, Xue QL, Tian J, Huang Y, Yeh SH, Fried LP. Associations of neutrophil and monocyte counts with frailty in community-dwelling disabled older women: results from the Women’s Health and Aging Studies I. Exp Gerontol. 2009; 44(8):511–6. https://doi.org/10.1016/j.exger.2009.05.005.PubMed

41.

Tang BM, Shojaei M, Teoh S, Meyers A, Ho J, Ball TB, Keynan Y, Pisipati A, Kumar A, Eisen DP, Lai K, Gillett M, Santram R, Geffers R, Schreiber J, Mozhui K, Huang S, Parnell GP, Nalos M, Holubova M, Chew T, Booth D, Kumar A, McLean A, Schughart K. Neutrophils-related host factors associated with severe disease and fatality in patients with influenza infection. Nat Commun. 2019; 10(1):3422. https://doi.org/10.1038/s41467-019-11249-y.PubMedPubMedCentral

42.

Mukherjee R, Kanti Barman P, Kumar Thatoi P, Tripathy R, Kumar Das B, Ravindran B. Non-Classical monocytes display inflammatory features: validation in sepsis and systemic lupus erythematous. Sci Rep. 2015; 5:13886.PubMedPubMedCentral

43.

Patel AA, Zhang Y, Fullerton JN, Boelen L, Rongvaux A, Maini AA, Bigley V, Flavell RA, Gilroy DW, Asquith B, Macallan D, Yona S. The fate and lifespan of human monocyte subsets in steady state and systemic inflammation. J Exp Med. 2017; 214(7):1913–23. https://doi.org/10.1084/jem.20170355.PubMedPubMedCentral

44.

Leins H, Mulaw M, Eiwen K, Sakk V, Liang Y, Denkinger M, Geiger H, Schirmbeck R. Aged murine hematopoietic stem cells drive aging-associated immune remodeling. Blood. 2018; 132(6):565–76. https://doi.org/10.1182/blood-2018-02-831065, http://www.bloodjournal.org/content/132/6/565.full.pdf.PubMedPubMedCentral

45.

Kovtonyuk LV, Fritsch K, Feng X, Manz MG, Takizawa H. Inflamm-aging of hematopoiesis, hematopoietic stem cells, and the bone marrow microenvironment. Front Immunol. 2016; 7:502. https://doi.org/10.3389/fimmu.2016.00502.PubMedPubMedCentral

46.

Pioli PD, Casero D, Montecino-Rodriguez E, Morrison SL, Dorshkind K. Plasma cells are obligate effectors of enhanced myelopoiesis in aging bone marrow. Immunity. 2019; 51(2):351–66. https://doi.org/10.1016/j.immuni.2019.06.006.PubMed

47.

Soysal P, Stubbs B, Lucato P, Luchini C, Solmi M, Peluso R, Sergi G, Isik AT, Manzato E, Maggi S, Maggio M, Prina AM, Cosco TD, Wu YT, Veronese N. Inflammation and frailty in the elderly: A systematic review and meta-analysis. Ageing Res Rev. 2016; 31:1–8. https://doi.org/10.1016/j.arr.2016.08.006.PubMed

48.

van Lier RAW, Kuijpers TW. The cellular immune system comes of age. J Allergy Clin Immunol. 2017; 139(6):1793–4. https://doi.org/10.1016/j.jaci.2017.02.023.PubMed

49.

Bupp MRG. Sex, the aging immune system, and chronic disease. Cell Immunol. 2015; 294(2):102–10. https://doi.org/10.1016/j.cellimm.2015.02.002.

50.

Pennell LM, Galligan CL, Fish EN. Sex affects immunity. J Autoimmun. 2012; 38(2-3):282–91. https://doi.org/10.1016/j.jaut.2011.11.013.

51.

Gordon EH, Hubbard RE. Do sex differences in chronic disease underpin the sex-frailty paradox?Mech Ageing Dev. 2019; 179:44–50. https://doi.org/10.1016/j.mad.2019.02.004.PubMed

52.

Furman D, Hejblum BP, Simon N, Jojic V, Dekker CL, Thiebaut R, Tibshirani RJ, Davis MM. Systems analysis of sex differences reveals an immunosuppressive role for testosterone in the response to influenza vaccination. Proc Natl Acad Sci. 2014; 111(2):869–74. https://doi.org/10.1073/pnas.1321060111.PubMed

53.

Van Acker HH, Capsomidis A, Smits EL, Van Tendeloo VF. CD56 in the immune system: more than a marker for cytotoxicity?Front Immunol. 2017; 8:892. https://doi.org/10.3389/fimmu.2017.00892.PubMedPubMedCentral

54.

Michel JJ, Griffin P, Vallejo AN. Functionally diverse NK-like T cells are effectors and predictors of successful aging. Front Immunol. 2016; 7:530. https://doi.org/10.3389/fimmu.2016.00530.PubMedPubMedCentral

55.

Li M, Yao D, Zeng X, Kasakovski D, Zhang Y, Chen S, Zha X, Li Y, Xu L. Age related human T cell subset evolution and senescence. Immun Ageing. 2019; 16(1):24. https://doi.org/10.1186/s12979-019-0165-8.PubMedPubMedCentral

56.

Saule P, Trauet J, Dutriez V, Lekeux V, Dessaint J-P, Labalette M. Accumulation of memory T cells from childhood to old age: Central and effector memory cells in CD4+ versus effector memory and terminally differentiated memory cells in CD8+ compartment. Mech Ageing Dev. 2006; 127(3):274–81. https://doi.org/10.1016/j.mad.2005.11.001.PubMed

57.

Schmaltz HN, Fried LP, Xue Q-L, Walston J, Leng SX, Semba RD. Chronic cytomegalovirus infection and inflammation are associated with prevalent frailty in community-dwelling older women. J Am Geriatr Soc. 2005; 53(5):747–54. https://doi.org/10.1111/j.1532-5415.2005.53250.x.PubMed

58.

Thomasini RL, Pereira DS, Pereira FSM, Mateo EC, Mota TN, Guimarães GG, Pereira LSM, Lima CX, Teixeira MM, Teixeira AL. Aged-associated cytomegalovirus and Epstein-Barr virus reactivation and cytomegalovirus relationship with the frailty syndrome in older women. PLOS ONE. 2017; 12(7):0180841. https://doi.org/10.1371/journal.pone.0180841.

59.

Matheï C, Vaes B, Wallemacq P, Degryse J. Associations between cytomegalovirus infection and functional impairment and frailty in the BELFRAIL Cohort. J Am Geriatr Soc. 2011; 59(12):2201–8. https://doi.org/10.1111/j.1532-5415.2011.03719.x.PubMed

60.

Knights D, Costello EK, Knight R. Supervised classification of human microbiota. FEMS Microbiol Rev. 2011; 35(2):343–59. https://doi.org/10.1111/j.1574-6976.2010.00251.x.PubMed

61.

Lee JW, Lee JB, Park M, Song SH. An extensive comparison of recent classification tools applied to microarray data. Comput Stat Data Anal. 2005; 48(4):869–85. https://doi.org/10.1016/j.csda.2004.03.017.

62.

Breiman L. Random Forests. Mach Learn. 2001; 45(1):5–32. https://doi.org/10.1023/a:1010933404324.

63.

Fried LP, Tangen CM, Walston J, Newman AB, Hirsch C, Gottdiener J, Seeman T, Tracy R, Kop WJ, Burke G, McBurnie MA. Frailty in older adults: Evidence for a phenotype. J Gerontol A Biol Sci Med Sci. 2001; 56(3):146–56. https://doi.org/10.1093/gerona/56.3.m146.

Titel: In-depth immune cellular profiling reveals sex-specific associations with frailty
verfasst von: Leonard Daniël Samson
A. Mieke H. Boots
José A. Ferreira
H. Susan J. Picavet
Lia G. H. de Rond
Mary-lène de Zeeuw-Brouwer
W. M. Monique Verschuren
Anne-Marie Buisman
Peter Engelfriet
Publikationsdatum: 01.12.2020
Verlag: BioMed Central
Erschienen in: Immunity & Ageing / Ausgabe 1/2020
Elektronische ISSN: 1742-4933
DOI: https://doi.org/10.1186/s12979-020-00191-z

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Hodgkin Lymphom: BrECADD-Regime übertrifft die Erwartungen

05.06.2024 ASCO 2024 Kongressbericht

Das Kombinationsregime BrECADD mit Brentuximab vedotin ermöglichte in der Studie HD21 beim fortgeschrittenen klassischen Hodgkin-Lymphom eine unerwartet hohe progressionsfreie Überlebensrate von 94,3% nach vier Jahren. Gleichzeitig war das Regime besser tolerabel als der bisherige Standard eBEACOPP.

Antikörper-Drug-Konjugat verdoppelt PFS bei Multiplem Myelom

05.06.2024 ASCO 2024 Nachrichten

Zwei Phase-3-Studien deuten auf erhebliche Vorteile des Antikörper-Wirkstoff-Konjugats Belantamab-Mafodotin bei vorbehandelten Personen mit Multiplem Myelom: Im Vergleich mit einer Standard-Tripeltherapie wurde das progressionsfreie Überleben teilweise mehr als verdoppelt.

Neuer TKI gegen CML: Höhere Wirksamkeit, seltener Nebenwirkungen

05.06.2024 Chronische myeloische Leukämie Nachrichten

Der Tyrosinkinasehemmer (TKI) Asciminib ist älteren Vertretern dieser Gruppe bei CML offenbar überlegen: Personen mit frisch diagnostizierter CML entwickelten damit in einer Phase-3-Studie häufiger eine gut molekulare Response, aber seltener ernste Nebenwirkungen.

Hereditäres Angioödem: Tablette könnte Akuttherapie erleichtern

05.06.2024 Hereditäres Angioödem Nachrichten

Medikamente zur Bedarfstherapie bei hereditärem Angioödem sind bisher nur als Injektionen und Infusionen verfügbar. Der Arzneistoff Sebetralstat kann oral verabreicht werden und liefert vielversprechende Daten.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Background

Results

Conclusions

Supplementary information

Publisher’s Note

Background

Methods

DCS subcohort selection

Frailty index

Whole blood lymphocyte phenotyping

Anti-cytomegalovirus antibodies

Statistical methods

Overall plan of analysis

Association studies

Random forest analysis

Results

Study population

Associations between leukocyte subpopulations and sex

Associations between leukocyte subpopulations and CMV serostatus

Relationship of frailty with leukocyte subpopulations

Associations between frailty and proportions of leukocyte subpopulations

Discussion

Conclusions

Supplementary information

Acknowledgements

Ethics approval and consent to participate

Consent for publication

Competing interests

Publisher’s Note

Supplementary information

Weitere Artikel der Ausgabe 1/2020

Age-related changes in T lymphocytes of patients with head and neck squamous cell carcinoma

COVID-19: age, Interleukin-6, C-reactive protein, and lymphocytes as key clues from a multicentre retrospective study

Can an effective SARS-CoV-2 vaccine be developed for the older population?

Autoimmune hemolytic anemia: current knowledge and perspectives

XX oder XY? Einfluss von Alter und Geschlecht auf COVID-19

The SENIEUR protocol and the efficacy of hepatitis B vaccination in healthy elderly persons by age, gender, and vaccine route

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Hodgkin Lymphom: BrECADD-Regime übertrifft die Erwartungen

Antikörper-Drug-Konjugat verdoppelt PFS bei Multiplem Myelom

Neuer TKI gegen CML: Höhere Wirksamkeit, seltener Nebenwirkungen

Hereditäres Angioödem: Tablette könnte Akuttherapie erleichtern

Update Innere Medizin